ALLFTD: Characterization of Frontotemporal Lobar Degeneration (FTLD) Disease Trajectories through Longitudinal Assessment
Longitudinal assessment of clinical and biomarker profiles in f-FTLD and s-FTLD can inform models of disease onset and progression, allowing analysis of disease trajectories and identification of the most sensitive clinical outcome measures over time. ALLFTD has been successful at recruiting and retaining a large active cohort to obtain detailed clinical and biomarker characterizations; data are available by request.
Authors
- Hilary W. Heuer (ORCID: https://orcid.org/0000-0002-3776-1685)
- Adam L. Boxer (ORCID: https://orcid.org/0000-0002-1215-5064)
- Noah R. Johnson (ORCID: https://orcid.org/0000-0002-0969-0066)
- Bradley F. Boeve (ORCID: https://orcid.org/0000-0002-4153-8187)
- Danielle Brushaber (ORCID: https://orcid.org/0009-0007-0543-0228)
- Leah K. Forsberg (ORCID: https://orcid.org/0000-0003-4086-9598)
- Carly Mester (ORCID: https://orcid.org/0000-0002-5863-946X)
- Tyler Kolander
- Howard J. Rosen
Institutions
- Mayo Clinic (US)
- WinnMed (US)
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.093231
- Citations
- 4
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 1.48